CHICAGO--(BUSINESS WIRE)--Meitheal Pharmaceuticals, Inc. (“Meitheal”), a fully integrated biopharmaceutical company based in Chicago and focused on the development and commercialization of generic ...
A Victorian-first study into a gentler IVF treatment hopes to reshape fertility care by eliminating the two-week ...
CHICAGO--(BUSINESS WIRE)--Meitheal Pharmaceuticals, Inc. (“Meitheal”), a fully integrated biopharmaceutical company based in Chicago and focused on the development and commercialization of generic ...
Dr. Piraye Yurttas Beim, Founder and CEO of Celmatix, stated, "Our oral FSH program stands to fundamentally change the landscape of fertility treatments. By offering a non-invasive alternative to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results